L DAmbrosio
Overview
Explore the profile of L DAmbrosio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sotgiu G, Rosales-Klintz S, Centis R, DAmbrosio L, Verduin R, Correia A, et al.
Int J Tuberc Lung Dis
. 2021 Mar;
25(2):126-133.
PMID: 33656424
Essential TB care in the European Union/European Economic Area (EU/EEA) comprises 21 standards for the diagnosis, treatment and prevention of TB that constitute the European Union Standards for Tuberculosis Care...
12.
Visca D, Ong C, Tiberi S, Centis R, DAmbrosio L, Chen B, et al.
Pulmonology
. 2021 Feb;
27(2):151-165.
PMID: 33547029
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The aim of the present review is to report the available evidence on the interaction between these two infections....
13.
Marinelli D, Mazzotta M, Scalera S, Terrenato I, Sperati F, DAmbrosio L, et al.
Ann Oncol
. 2020 Sep;
31(12):1746-1754.
PMID: 32866624
Background: Immune checkpoint inhibitors (ICIs) have demonstrated significant overall survival (OS) benefit in lung adenocarcinoma (LUAD). Nevertheless, a remarkable interpatient heterogeneity characterizes immunotherapy efficacy, regardless of programmed death-ligand 1 (PD-L1)...
14.
Visca D, Centis R, DAmbrosio L, Munoz-Torrico M, Chakaya J, Tiberi S, et al.
Int J Tuberc Lung Dis
. 2020 Jul;
24(7):720-722.
PMID: 32718406
No abstract available.
15.
Munoz-Torrico M, Cid-Juarez S, Gochicoa-Rangel L, Torre-Bouscolet L, Salazar-Lezama M, Villarreal-Velarde H, et al.
Int J Tuberc Lung Dis
. 2020 Jul;
24(7):700-705.
PMID: 32718403
Evidence on the impact of tuberculosis (TB) treatment on lung function is scarce. The aim of this study was to evaluate post-treatment sequelae in drug-susceptible and drug-resistant-TB (DR-TB) cases in...
16.
Motta I, Centis R, DAmbrosio L, Garcia-Garcia J, Goletti D, Gualano G, et al.
Pulmonology
. 2020 May;
26(4):233-240.
PMID: 32411943
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease...
17.
Palmerini E, Jones R, Setola E, Picci P, Marchesi E, Luksch R, et al.
Acta Oncol
. 2018 Mar;
57(7):958-964.
PMID: 29533113
Background: Data on temozolomide (TEM) and irinotecan (IRI) activity in recurrent Ewing sarcoma (EWS), especially in adult patients, are limited. Methods: Patients receiving TEM 100 mg/m/day oral, and IRI 40 ...
18.
Tiberi S, Munoz-Torrico M, Duarte R, Dalcolmo M, DAmbrosio L, Migliori G
Pulmonology
. 2018 Mar;
24(2):86-98.
PMID: 29487031
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease. With growing drug resistance the epidemic remains and will require significant attention and investment for...
19.
DAmbrosio L, Bothamley G, Caminero Luna J, Duarte R, Guglielmetti L, Munoz Torrico M, et al.
Pulmonology
. 2017 Dec;
24(2):132-141.
PMID: 29229274
As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as 'TB Consilium'. This body usually includes different...
20.
Tiberi S, DAmbrosio L, Centis R, Migliori G
Int J Infect Dis
. 2017 Nov;
65:133-134.
PMID: 29122690
No abstract available.